Effects of the population screening into breast cancer;Effecten van het bevolkingsonderzoek naar borstkanker

Nederlands Tijdschrift voor Geneeskunde

Volumn 157, Issue 17, 2013, Pages

  Verbeek, André L M ^a   Broeders, Mireille J M ^a   Otto, Suzie J ^b   Fracheboud, Jacques ^b   Otten, J D M ^a   Holland, Roland ^c   Den Heeten, G J ^c   De Koning, Harry J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Landelijk Referentiecentrum Bevolkingsonderzoek Kanker   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SCREENING; HUMAN; MASS SCREENING; AGED; BREAST TUMOR; EARLY DIAGNOSIS; FEMALE; MAMMOGRAPHY; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE; REVIEW;

AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS;

EID: 84877866803     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Broeders M, Moss S, Nyström L, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19 Suppl 1:14-25.
2. Landelijk Evaluatie Team voor bevolkingsonderzoek naar Borstkanker (LETB). LETB tussenrapportage 2011: Belangrijkste resultaten 2008-2009 bevolkingsonderzoek borstkanker. Rotterdam/Nijmegen; 2011.
3. Nickson C, Mason KE, English DR, Kavanagh AM. Mammographic screening ans breast cancer mortality: a case-control study and metaanalysis. Cancer Epidemiol Biomarkers Prev. 2012;21:1479-88.
4. Otto SJ, Fracheboud J, Verbeek AL, et al. Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2012;21:66-73.
5. Paap E, Holland R, Heeten GJ, et al. A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes Control. 2010;21:1569-73.
6. Van Schoor G, Moss SM, Otten JD, et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011;104:910-4.
7. Puliti D, Miccinesi G, Collina N, et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer. 2008;99:423-7.
8. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer. 2008;98:206-9.
9. Roder D, Houssami N, Farshid G, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat. 2008;108:409-16. (Pubitemid 351431073)
10. Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol. 2007;48:948-55. (Pubitemid 350022989)
11. Elmore JG, Reisch LM, Barton MB, et al. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst. 2005;97:1035-43. (Pubitemid 41417920)
12. Fielder HM, Warwick J, Brook D, et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen. 2004;11:194-8. (Pubitemid 40006743)
13. Van Schoor G, Paap E, Broeders MJ, Verbeek AL. Residual confounding after adjustment for age: a minor issue in breast cancer screening effectiveness. Eur J Epidemiol. 2011;26:585-8.
14. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363:1203-10.
15. Autier P, Boniol M, La Vecchia C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 2010;341:c3620.
16. Bonneux LG, Autier P. Bevolkingsonderzoek naar borstkanker loont niet. Ned Tijdschr Geneeskd. 2011;155:A3774.
17. Jørgensen KJ, Zahl PH, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ. 2010;340:c1241.
18. Tabár L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658-63.
19. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breastcancer mortality: a systematic review. Lancet. 2003;361:1411-7. (Pubitemid 36515040)
20. Otten JD, Broeders MJ, Fracheboud J, Otto SJ, De Koning HJ, Verbeek AL. Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006. Int J Cancer. 2008;123:1929-34.
21. Landelijk Evaluatie Team voor bevolkingsonderzoek naar Borstkanker (LETB). Landelijke evaluatie van bevolkingsonderzoek naar borstkanker in Nederland 1990-2007 (LETB XII). Rotterdam/Nijmegen; 2009.
22. Otten J D M, Karssemeijer N, Hendriks JH, et al. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst. 2005;97:748-54. (Pubitemid 40872381)
23. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302:1685-92.
24. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587.
25. De Gelder R, Heijnsdijk EA, Van Ravesteyn NT, Fracheboud J, Draisma G, De Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev. 2011;33:111-21.
26. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738-47.
27. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:1778-86.